The International Colloquium on Lung and Airway Fibrosis is a biennial non-profit meeting convening to discuss cutting-edge advancements in pathogenesis, management and therapies for pulmonary fibrosis. As the key subspecialist conference for lung fibrosis, ICLAF fosters collaboration amongst the international community, supports early career researchers and engages stakeholders including patient advocacy groups and industry partners.
Sydney has the privilege of hosting this event in 2026, which sees world renowned experts in the area of lung and airway fibrosis come together for five days of seminars and discussions. Against the background of beautiful Sydney Harbour, delegates will be treated to a full program of inspiring presentations, vibrant plenary sessions and engaging poster presentations. ICLAF is unique in that it is the only international meeting dedicated to the understanding and treatment of lung and airways fibrosis.
It's been over 40 years since the first meeting in London in 1982, which brought together scientists from around the world to discuss and better understand the mechanisms driving lung fibrosis. We have now seen this community grow significantly and with it, the development of novel therapies for lung and airway fibrosis.
The purpose of this meeting is to provide a forum for the presentation of research findings and technologies, the exchange of ideas and the fostering of collaboration between discovery scientists, translational and clinical researchers, as well as our industry partners.
Suite G.02, Building A, 4 Talavera Road
Macquarie Park NSW 2113
P: +61 2 8333 8999
E: meetings@medicalmeetings.com.au
ICLAF 2026 is being hosted by the Centre of Research Excellence in Pulmonary Fibrosis (CRE-PF)